Diatrizoate
FDA Approved
Description
Diatrizoate is a contrast agent used in radiographic imaging. It enhances the visibility of internal structures during X-rays and CT scans. It may be useful in identifying hemangiomas.
Indications & Therapeutic Use
Radiographic contrast agent, hemangioma imaging
Linked Diseases:
Global Availability (3 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Diatrizoate
| Generic Name | Diatrizoate |
| Brands | 1 brand available |
| Active Ingredient | Diatrizoate |
| Drug Class | Radiographic contrast agent |
| Manufacturer | GE Healthcare |
| Dosage Forms | Solution for injection |
| Medical Code | V08AA01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Countries | 3 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations4 Validated Nodes